Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 13, 2009New England Journal of MedicineOpen Access

Bevacizumab in Hereditary Hemorrhagic Telangiectasia

View Full Paper
Ask AI
Bookmark
Share

Authors

PBPrithviraj BoseThe University of Texas MD Anderson Cancer CenterJHJennifer Holter‐ChakrabartyOklahoma City UniversityGSGeorge B. SelbyUniversity of Oklahoma Health Sciences Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bose et al. (2009) studied this question.

synapsesocial.com/papers/6a919f1fc353f7d2142eb54chttps://doi.org/10.1056/nejmc0901421
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1VEGF Gene Delivery to Myocardium2000 · 700 citations
  2. 2Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia2008 · 162 citations
  3. 3Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)2000 · 1,766 citations